middle.news

Actinogen Accelerates Alzheimer’s Trial with Expanded Enrollment and Early Screening Close

9:13am on Monday 20th of October, 2025 AEDT Healthcare
Read Story

Actinogen Accelerates Alzheimer’s Trial with Expanded Enrollment and Early Screening Close

9:13am on Monday 20th of October, 2025 AEDT
Key Points
  • pTau biomarker screening closes October 31, one month ahead of schedule
  • Total enrolment target increased to approximately 240 participants
  • Currently 180 participants enrolled, with 60 more expected by year-end
  • Final topline results projected for mid Q4 2026
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about ACW
OPEN ARTICLE